TickerTain
$SPCX····$NVDA····$MSFT····$GOOGL····$ANTHROPIC·$TSLA····$CRWV····$NBIS····$HIMS····$TSM····$ASML····$FIGURE·$LYFT····$UBER····$SNOW····$META····$ELEVENLABS·$CURSOR·$COGNITION·$OPENAI·$AAPL····$RKLB····$XAI·$AMZN····$AMD····$000660.KS····$INTC····
← newsroom
$SEQUOIA · Sequoia chosen for seed and Series A for patient capital and founder alignment
now playing · $SEQUOIA
$LINEARbullish· high· poskarri saarinen
Linear compounds efficiently: ~$80M raised, default alive since year 2, doubling revenue yearly
Linear has raised only ~$70-80M across three rounds, reached default alive within two years, and doubles revenue annually with a tiny team (120 people at $10-15M ARR at Series B),…
$EXCELbullish· high· poskarri saarinen
Excel led Series B and C for patient, long-term orientation
Linear chose Excel for Series B and C because they are a large, established firm that doesn't care about markups and simply wants the company to be best-in-class in its market.
$SEQUOIAbullish· high· poskarri saarinen
Sequoia chosen for seed and Series A for patient capital and founder alignment
Karri Saarinen selected Sequoia for Linear's first two rounds because they align with a long-term, patient approach and don't pressure for markups; he deliberately chose a less ex…